{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:27:24Z","timestamp":1787646444451,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,25]]},"DOI":"10.7759\/cureus.115131","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:01:27Z","timestamp":1787644887000},"source":"Crossref","is-referenced-by-count":0,"title":["SLC52A3-Related Riboflavin Transporter Deficiency in Two Saudi Siblings: A Case Report"],"prefix":"10.7759","author":[{"given":"Fadi","family":"Busaleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Almajhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola H","family":"Alabbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal M","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham  R","family":"Alhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaliah Y","family":"Alhejji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariyyah  A","family":"Al Jamea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnah F","family":"Alomran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shomos H","family":"Aldulaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema M","family":"Almohammad Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar F","family":"Alqadeep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.02.006","article-title":"Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54","volume":"86","author":"Green P","year":"2010","unstructured":"Green P, Wiseman M, Crow YJ, et al.. Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet. 2010, 86:485-9. 10.1016\/j.ajhg.2010.02.006","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch AM","year":"2011","unstructured":"Bosch AM, Abeling NG, Ijlst L, et al.. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis. 2011, 34:159-64. 10.1007\/s10545-010-9242-z","journal-title":"J Inherit Metab Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-83","article-title":"The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives","volume":"7","author":"Bosch AM","year":"2012","unstructured":"Bosch AM, Stroek K, Abeling NG, Waterham HR, Ijlst L, Wanders RJ. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives. Orphanet J Rare Dis. 2012, 7:83. 10.1186\/1750-1172-7-83","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws161","article-title":"Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease","volume":"135","author":"Johnson JO","year":"2012","unstructured":"Johnson JO, Gibbs JR, Megarbane A, et al.. Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain. 2012, 135:2875-82. 10.1093\/brain\/aws161","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-016-9924-2","article-title":"Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience","volume":"39","author":"Jaeger B","year":"2016","unstructured":"Jaeger B, Bosch AM. Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience. J Inherit Metab Dis. 2016, 39:559-64. 10.1007\/s10545-016-9924-2","journal-title":"J Inherit Metab Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2013.09.006","article-title":"Brown-Vialetto-van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features","volume":"18","author":"Spagnoli C","year":"2014","unstructured":"Spagnoli C, Pitt MC, Rahman S, de Sousa C. Brown-Vialetto-van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features. Eur J Paediatr Neurol. 2014, 18:231-4. 10.1016\/j.ejpn.2013.09.006","journal-title":"Eur J Paediatr Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13084","article-title":"Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency","volume":"58","author":"Menezes MP","year":"2016","unstructured":"Menezes MP, O'Brien K, Hill M, et al.. Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency. Dev Med Child Neurol. 2016, 58:848-54. 10.1111\/dmcn.13084","journal-title":"Dev Med Child Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2011.04142.x","article-title":"Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome","volume":"54","author":"Anand G","year":"2012","unstructured":"Anand G, Hasan N, Jayapal S, et al.. Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome. Dev Med Child Neurol. 2012, 54:187-9. 10.1111\/j.1469-8749.2011.04142.x","journal-title":"Dev Med Child Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006498","article-title":"Child neurology: Brown-Vialetto-Van Laere syndrome: dramatic visual recovery after delayed riboflavin therapy","volume":"91","author":"Bamaga AK","year":"2018","unstructured":"Bamaga AK, Maamari RN, Culican SM, Shinawi M, Golumbek PT. Child neurology: Brown-Vialetto-Van Laere syndrome: dramatic visual recovery after delayed riboflavin therapy. Neurology. 2018, 91:938-41. 10.1212\/WNL.0000000000006498","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.10.017","article-title":"Oral therapy for riboflavin transporter deficiency - what is the regimen of choice?","volume":"61","author":"Gorcenco S","year":"2019","unstructured":"Gorcenco S, Vaz FM, Tracewska-Siemiatkowska A, et al.. Oral therapy for riboflavin transporter deficiency - what is the regimen of choice?. Parkinsonism Relat Disord. 2019, 61:245-7. 10.1016\/j.parkreldis.2018.10.017","journal-title":"Parkinsonism Relat Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0883073819893159","article-title":"The clinical journey of patients with riboflavin transporter deficiency type 2","volume":"35","author":"Amir F","year":"2020","unstructured":"Amir F, Atzinger C, Massey K, Greinwald J, Hunter LL, Ulm E, Kettler M. The clinical journey of patients with riboflavin transporter deficiency type 2. J Child Neurol. 2020, 35:283-90. 10.1177\/0883073819893159","journal-title":"J Child Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0590","article-title":"Brief resolved unexplained events (formerly apparent life-threatening events) and evaluation of lower-risk infants","volume":"137","author":"Tieder JS","year":"2016","unstructured":"Tieder JS, Bonkowsky JL, Etzel RA, et al.. Brief resolved unexplained events (formerly apparent life-threatening events) and evaluation of lower-risk infants. Pediatrics. 2016, 137:10.1542\/peds.2016-0590","journal-title":"Pediatrics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0852-4","article-title":"Congenital myasthenic syndromes in 2018","volume":"18","author":"Engel AG","year":"2018","unstructured":"Engel AG. Congenital myasthenic syndromes in 2018. Curr Neurol Neurosci Rep. 2018, 18:46. 10.1007\/s11910-018-0852-4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22130","article-title":"Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients","volume":"33","author":"Abicht A","year":"2012","unstructured":"Abicht A, Dusl M, Gallenm\u00fcller C, et al.. Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients. Hum Mutat. 2012, 33:1474-84. 10.1002\/humu.22130","journal-title":"Hum Mutat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri E","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, et al.. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018, 28:103-15. 10.1016\/j.nmd.2017.11.005","journal-title":"Neuromuscul Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215114003375","article-title":"Auditory neuropathy spectrum disorder with Brown-Vialetto-Van Laere syndrome: challenges in hearing rehabilitation","volume":"129","author":"Chandran R","year":"2015","unstructured":"Chandran R, Alexander M, Naina P, Balraj A. Auditory neuropathy spectrum disorder with Brown-Vialetto-Van Laere syndrome: challenges in hearing rehabilitation. J Laryngol Otol. 2015, 129:504-8. 10.1017\/S0022215114003375","journal-title":"J Laryngol Otol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/14670100.2018.1534035","article-title":"Cochlear implantation in children with auditory neuropathy: lessons from Brown-Vialetto-Van Laere syndrome","volume":"20","author":"Anderson P","year":"2019","unstructured":"Anderson P, Schaefer S, Henderson L, Bruce IA. Cochlear implantation in children with auditory neuropathy: lessons from Brown-Vialetto-Van Laere syndrome. Cochlear Implants Int. 2019, 20:31-8. 10.1080\/14670100.2018.1534035","journal-title":"Cochlear Implants Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5152\/iao.2022.21159","article-title":"Cochlear implant in Brown-Vialetto-Van Laere syndrome patient","volume":"18","author":"do Amaral MS","year":"2022","unstructured":"do Amaral MS, Massuda ET, Mitikami Fen\u00f3lio GH, Barbosa Reis AC, Angelo Hyppolito M. Cochlear implant in Brown-Vialetto-Van Laere syndrome patient. J Int Adv Otol. 2022, 18:192-5. 10.5152\/iao.2022.21159","journal-title":"J Int Adv Otol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-026-02106-w","article-title":"SLC52A3-related Brown-Vialetto-Van Laere syndrome: a large cohort from the Arabian Peninsula","volume":"34","author":"Al Shamsi B","year":"2026","unstructured":"Al Shamsi B, Al Momen M, Al Kindy F, et al.. SLC52A3-related Brown-Vialetto-Van Laere syndrome: a large cohort from the Arabian Peninsula. Eur J Hum Genet. 2026, 34:777-82. 10.1038\/s41431-026-02106-w","journal-title":"Eur J Hum Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2023.04.004","article-title":"Normal outcome with prenatal intervention for riboflavin transporter defect","volume":"144","author":"Elks N","year":"2023","unstructured":"Elks N, Wilmshurst JM, Raga SV. Normal outcome with prenatal intervention for riboflavin transporter defect. Pediatr Neurol. 2023, 144:16-8. 10.1016\/j.pediatrneurol.2023.04.004","journal-title":"Pediatr Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522541-slc52a3-related-riboflavin-transporter-deficiency-in-two-saudi-siblings-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:01:28Z","timestamp":1787644888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522541-slc52a3-related-riboflavin-transporter-deficiency-in-two-saudi-siblings-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.115131","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}